Yoga Therapy Research, Individualized Yoga Therapy and Call It Yoga Therapy

Criswell, Eleanor; Wheeler, Amy; Lauttamus, Mary Partlow

doi:10.17761/ijyt.24.1.a472jr148535634j

Cited by 1 publication

(1 citation statement)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, the movement protocol for this trial was inspired greatly by the principles of Hanna Somatics (Thomas Hanna) and Somatic Yoga (Eleanor Criswell), both rooted in Hatha Yoga. 59-61 Stresses and traumas create reflex patterns in the body that lead to chronic muscular contractions, which, over time, cannot be voluntarily relaxed. These states of contraction cause many ongoing symptoms such as poor posture, decreased flexibility and balance, debilitating pain, and overall decreased QOL.…”

Section: Methodsmentioning

confidence: 99%

Impact of Somatic Yoga and Meditation on Fall Risk, Function, and Quality of Life for Chemotherapy-Induced Peripheral Neuropathy Syndrome in Cancer Survivors

Galantino

Tiger²,

Brooks

et al. 2019

Integr Cancer Ther

View full text Add to dashboard Cite

Objective . Chemotherapy-induced peripheral neuropathy (CIPN) syndrome causes significant pain as an adverse effect of treatment, with few nonpharmacological interventions tested. A somatic yoga and meditation (SYM) intervention on functional outcomes and quality of life (QOL) was investigated. Design and methods . Individuals diagnosed with CIPN were enrolled in an open-label, single-arm, mixed-methods feasibility trial. Participants and Setting . In an outpatient rehabilitation center, ten participants with median age 64.4 years (47-81) attended 61% of the sessions with no adverse events. Intervention . SYM twice a week for 8 weeks for 1.5 hours, with home program and journaling. Main outcome measures . Primary functional outcomes included Sit and Reach (SR), Functional Reach (FR), and Timed Up and Go (TUG). Self-reported Patient Neurotoxicity Questionnaire (PNQ) and Functional Assessment of Cancer Therapy—Neurotoxicity (FACT-GOG-NTX) were secondary CIPN outcomes. Biomarkers included salivary cortisol (stress) and bioesthesiometer (vibration). Results: Quantitative findings . Significant improvements were found in flexibility (SR; P = .006); balance (FR; P = .001) and fall risk (TUG; P = .004). PNQ improved significantly ( P = .003) with other measures improving non-significantly. Qualitative findings . Five themes emerged: (1) vacillation of CIPN pain perception over time; (2) transferability of skills to daily activities; (3) improvement in physical function; (4) perceived relaxation as an effect of SYM; and (5) group engagement provided a social context for not feeling isolated with CIPN. Conclusion . Preliminary data suggest SYM may improve QOL, flexibility, and balance in cancer survivors with CIPN, with a fully powered randomized controlled trial indicated. Trial registration: NCT03786055

show abstract

Section: Methodsmentioning

confidence: 99%